21259 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Sub-classes:METHODS FOR TRAPPING AND BARCODING DISCRETE BIOLOGICAL UNITS IN HYDROGEL
#2PHOTOACOUSTIC VAPORIZATION OF EXOSKELETAL AND ENDOSKELETAL DROPLETS
#3ANTIOXIDANT OPHTHALMIC EMULSION
#4COMPOSITIONS AND DOSAGE FORMS FOR ORAL DELIVERY
#5TOPICAL OPHTHALMOLOGICAL COMPOSITIONS
#6CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION
#7INFLAMMATORY CONDITION-SPECIFIC DRUG-RELEASING HYDROGEL FOR OCULAR INJECTION
#8COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES
#9TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#10THERMAL ENERGY SYSTEM FOR ADMINISTERING ACTIVE AGENTS
#11METERED DOSE INHALERS AND SUSPENSION COMPOSITIONS
#12Therapeutic Formulation
#13OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
#14PHARMACEUTICAL TOPICAL FORMULATIONS OF LIDOCAINE AND KETAMINE
#15COMPOSITIONS FOR TOPICAL AND TRANSDERMAL DRUG DELIVERY
#16FORMULATION FOR STIMULATING HAIR GROWTH AND IMPROVING QUALITY AND METHOD OF PREPARATION OF THE SAME
#17METERED DOSE INHALER FOR IPRATROPIUM BROMIDE SOLUTION
#18N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF
#19FORMULATION OF DELGOCITINIB IN THE FORM OF A CREAM
#20Pharmaceutical Combinations For The Treatment Of Cancer
#21PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#22SEMIFLUORINATED ALKANE TETRACYCLINE COMBINATION COMPOSITIONS FOR TREATMENT OF MALAR EDEMA
#23TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUE
#24Topical Roflumilast Aerosol Foams
#25QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP
#26SELENIUM DISULFIDE COMPOSITIONS FOR USE IN TREATING MEIBOMIAN GLAND DYSFUNCTION
#27POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF
#28PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE
#29PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS
#30TRANS-CYCLOOCTENE PRODRUG OF MONOMETHYL AURISTATIN E
#31COMPOSITIONS, DEVICES AND METHODS FOR RESPRITORY DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS
#32ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES
#33PETROLATUM-BASED PHMB COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASE
#34ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES
#35COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MOISTURE-ASSOCIATED SKIN DAMAGE
#36TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
#37TOPICAL FORMULATION FOR A JAK INHIBITOR
#38COMBINATION OF ALBUTEROL AND BUDESONIDE FOR THE TREATMENT OF ASTHMA
#39O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#40ANILINE-DERIVATIVE-CONTAINING EXTERNAL PREPARATION FOR SKIN
#41POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF
#42MEDICAMENT FOR TREATMENT OF TRAUMA
#43PETROLATUM-BASED PHMB COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASE
#44A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
#45A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
#46COMPOSITIONS AND METHODS OF USE FOR TREATING ABERRANT INFLAMMATION IN PERI-OCULAR SECRETORY GLANDS OR AT THE OCULAR SURFACE
#47TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF- LIFE
#48SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME
#49TOPICAL TETRACYCLINE COMPOSITIONS
#50AEROSOL FORMULATION FOR COPD
#51TOPICAL FORMULATION FOR JAK INHIBITOR
#52MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
#53COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF
#54TOPICAL ANTIBIOTIC
#55COMPOSITIONS AND METHODS FOR TREATING PRURITIS ANI AND ANAL FISSURES
#56TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS
#57Pharmaceutical Combinations For The Treatment Of Cancer
#58PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING
#59EMULSION FOR NON-INVASIVE BLOOD-BRAIN BARRIER TRANSIENT OPENING AND CONTROLLED DRUG RELEASE INTO THE BRAIN
#60COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISORDERS
#61DRIED NANOPARTICLE COMPOSITIONS
#62SALBUTAMOL DELIVERY COMPOSITIONS, DEVICES AND METHODS
#63COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES
#64THERAPEUTIC COMPOUNDS AND METHODS
#65INSECT PRODUCTION SYSTEMS AND METHODS
#66COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS
#67INHALABLE FORMULATIONS
#68COMPOSITIONS AND METHODS FOR IMPROVING BONE HEALTH USING SELF-EMULSIFYING FORMULATIONS OF DIINDOLYLMETHANE
#69THERAPEUTIC PRODUCT IN THE FORM OF A DENTAL GEL
#70PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
#71CONTAINER SYSTEM AND PHARMACEUTICAL FOAM COMPOSITION COMPRISING BETAMETHASONE
#72COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#73METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF
#74A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS
#75PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION
#76PHARMACEUTICAL COMPOSITION COMPRISING SALBUTAMOL
#77PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE
#78FLEECE FOR ORAL PRODUCT WITH RELEASABLE COMPONENT
#79SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME
#80TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
#81SALBUTAMOL DELIVERY FORMULATIONS, DEVICES AND METHODS
#82CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
#83USE OF LACTIC ACID IN POSTMENOPAUSAL WOMEN
#84PROPELLANTS FOR ANTICHOLINERGIC AGENTS IN PRESSURIZED METERED DOSE INHALERS
#85TOPICAL OPHTHALMOLOGICAL COMPOSITIONS
#86OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY
#87POROUS CARBON MATERIAL COMPOSITES AND THEIR PRODUCTION PROCESS, ADSORBENTS, COSMETICS, PURIFICATION AGENTS, AND COMPOSITE PHOTOCATALYST MATERIALS
#88Method for Treatment of Microbial Infections
#89TREATMENT OF ALOPECIA AREATA
#90STERILE TOPICAL SALINE PUTRESCINE FORMULATION AND USES THEREOF
#91COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES
#92TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS
#93METERED DOSE INHALERS AND SOLUTION COMPOSITIONS
#94Yeast B-Glucan Emulsion, Methods and Uses Thereof
#95PATCH AND PRODUCTION METHOD THEREOF
#96ANTIMICROBIAL COATING MATERIAL AND METHODS FOR PREPARATION AND APPLICATION TO SURFACES
#97COMPOSITIONS AND DOSAGE FORMS FOR ORAL DELIVERY
#98COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#99FOAM COMPOSITIONS FOR TREATING CLOSTRIDIOIDES DIFFICILE INFECTIONS
#100N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF
#101COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES
#102LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
#103FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS
#104TOFACITINIB-CONTAINING ANHYDROUS ELASTOMER-BASED GEL FORMULATIONS
#105PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TSLP ANTIBODY
#106PRODUCTION OF LIGNIN DERIVED RENEWABLE LUBRICANTS
#107SELENIUM DISULFIDE COMPOSITIONS FOR USE IN TREATING MEIBOMIAN GLAND DYSFUNCTION
#108EMULSION FOR USE IN THE TREATMENT OF ROSACEA
#109FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING
#110TOPICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY SKIN DISEASES
#111OXYGEN-ENRICHED SILICONE OIL AND PERFLUOROCARBON AS VITREORETINAL TAMPONADE
#112Liquid Protein Formulations Containing Ionic Liquids
#113Topical roflumilast formulation having improved delivery and plasma half-life
#114TOPICAL PHARMACEUTICAL COMPOSITIONS
#115NUCLEIC ACID SENSOR AGONIST COMPOSITIONS AND USES THEREOF
#116Device For Administration of a Therapeutic Agent Solution and Method Comprising Same
#117TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS
#118NOVEL SELECTIVE ANTIMICROBIAL FUSION PEPTIDES
#119COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#120COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#121COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#122TREATMENT OF TUNNELING WOUNDS USING METRONIDAZOLE-CONTAINING COMPOSITIONS
#123COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#124Topical formulation for a JAK inhibitor
#125METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER
#126FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
#127Dried nanoparticle compositions
#128FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS
#129PHOSPHOLIPID COMPOUNDS AND FORMULATIONS
#130Liquid Protein Formulations Containing Viscosity-Lowering Agents
#131TOPICAL COMPOSITIONS CONTAINING ANTHRANILIC ACID DERIVATIVES AND METHODS FOR TREATING SKIN DISORDERS
#132CANCER THERAPY
#133Topical medicament for use in treatment of anorectal inflammation
#134ASSISTED LOADING OF HYDROPHOBIC MOLECULES INTO LIPOSOMES
#135TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#136COMPOSITION FOR EXTERNAL APPLICATION
#137PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#138TERPENE-ENRICHED CANNABINOID COMPOSITION
#139SKIN CREAM FOR REDUCING BED SORES
#140CANNABINOID AND MENTHOL TRANSDERMAL DELIVERY SYSTEMS AND METHODS
#141COMPOSITIONS AND METHODS FOR TREATING PRURITIS ANI AND ANAL FISSURES
#142MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS, METHODS OF MANUFACTURING AND USE OF THE SAME
#143Topical composition containing antioxidants
#144PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF AND CONTAINING SULFUR-BASED ANTIOXIDANT
#145Mucoadhesive Gel Composition
#146COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES
#147COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED THIAZOLIDINEDIONES AND LIPOSOME-ENCAPSULATED VASODILATORS, AND THEIR USE TO AMELIORATE ATHEROMA
#148TOPICAL TREATMENT FOR ANIMALS
#149TOPICAL COMPOSITIONS COMPRISING PEA PROTEINS AND POLYPHENOLS
#150Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
#151Cannabis composition
#152TOPICAL NAFTIFINE COMPOSITIONS
#153SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME
#154ALDH-2 inhibitor compounds and methods of use
#155ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE
#156PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID
#157OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES
#158HYDROPHOBIC COMPOSITIONS INCLUDING A HYDROPHILIC ACTIVE INGREDIENT AND METHODS RELATING THERETO
#159IRAK4 Inhibitors and Topical Uses Thereof
#160COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT
#161COMPOSITIONS AND METHODS FOR TREATING PRURITIS ANI AND ANAL FISSURES
#162COMPOSITIONS AND METHODS OF USE FOR TREATING ABERRANT INFLAMMATION IN PERI-OCULAR SECRETORY GLANDS OR AT THE OCULAR SURFACE
#163Treatment of erectile dysfunction and other indications
#164WATER-SOLUBLE COMPLEX CONTAINING BETA BLOCKER AND LECITHIN
#165Topical roflumilast formulation having improved delivery and plasma half-life
#166COMPOSITIONS COMPRISING A VEGETABLE CHONDROITIN OR AN ANALOGUE THEREOF AND THE USE THEREOF IN THE TREATMENT OF DISORDERS OF THE MUCOUS MEMBRANE OF THE ORAL, PHARYNGO-LARYNGEAL AND/OR GASTRO-OESOPHAGEAL TRACT
#167TOPICAL OPHTHALMOLOGICAL COMPOSITIONS
#168PRESSURED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION
#169TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF COMPOSITIONS
#170CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
#171SEMIFLUORINATED ALKANE COMPOSITIONS
#172Wound-care composition and method of use
#173TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
#174TOFACITINIB-CONTAINING ANHYDROUS ELASTOMER-BASED GEL FORMULATIONS
#175Stable Topical Formulations of 1(R)-4-(5-(4-Methoxy-3-Propoxphenyl)Pyridin-3-YL)-1,2-OX-Aborolan-2-OL
#176Topical roflumilast formulation having improved delivery and plasma half-life
#177TOPICAL ROFLUMILAST COMPOSITIONS AND USES THEREOF
#178FENOLDOPAM TOPICAL FORMULATIONS FOR TREATING SKIN DISORDERS
#179ANTI-INFECTIVE METHODS, COMPOSITIONS, AND DEVICES
#180AK3287 PREPARATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#181Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
#182Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
#183TOPICAL FORMULATION FOR A JAK INHIBITOR
#184STABLE PHARMACEUTICAL TOPICAL FORMULATION CONTAINING IMMUNOSUPPRESSANT FOR TREATING DERMATOLOGICAL CONDITION
#185THERMO-SENSITIVE PERMEATION ENHANCING FORMULATIONS FOR DRUG DELIVERY
#186PHARMACEUTICAL COMPOSITION
#187Trans-Cyclooctene Bioorthogonal Agents and Uses in Cancer and Immunotherapy
#188Pharmaceutical compositions of testosterone
#189CURCUMIN COMPOSITIONS FOR OSTEOARTHRITIS AND JOINT WELLNESS
#190Topical antibiotic
#191TOPICAL PHARMACEUTICAL COMPOSITIONS
#192Nano-Emulsion Based Compositions, Methods for Their Preparation and Their Use in Delivery of Active Ingredients
#193ANTI-ACNE COMPOSITIONS
#194Method for treating pruritus
#195Topical Roflumilast Aerosol Foams
#196TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
#197LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
#198Topical Ointment Composition, Methods Of Use, And Methods Of Preparation
#199PHARMACEUTICAL OPHTHALMIC COMPOSITIONS FOR PROTECTION AGAINST BLUE LIGHT
#200OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITIS
#201Compositions and methods for treating pruritis ani and anal fissures
#202MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
#203AEROSOL FORMULATION FOR COPD
#204FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES
#205OPHTHALMIC SUSPENSION COMPOSITION
#206O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#207Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and Tetrahydrocannabinol (THC)
#208TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS
#209Inhibitors of spore germination
#210PHARMACEUTICAL COMPOSITIONS
#211TOPICAL PHARMACEUTICAL COMPOSITIONS
#212Therapeutic compounds and methods
#213ADJUVANT FORMULATIONS COMPRISING TLR4 AGONISTS AND METHODS OF USING THE SAME
#214DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES
#215ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES
#216TOPICAL PHARMACEUTICAL COMPOSITION IN GEL FORM COMPRISING AT LEAST AMITRIPTYLINE FOR USE IN THE TREATMENT OF NEUROPATHIC PHANTOM LIMB PAIN
#217Topical formulations containing mTOR inhibitors
#218S1P RECEPTOR MODULATORS
#219CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY
#220Method for Treating Pruritus
#221PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION
#222Combination therapy for cancer treatment
#223OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
#224SUSTAINED-RELEASE 9-CIS RETINOIC ACID IMPLANTABLE DRUG DELIVERY PELLETS FOR THE PREVENTION OF POSTSURGICAL EDEMA AND LYMPHEDEMA
#225Topical compositions comprising pea proteins and polyphenols
#226TOPICAL THERAPY FOR THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) AND CERVICAL CANCER USING NANOPARTICLES OF TAXANES
#227METHOD FOR REDUCING SKIN SENSITIZATION OF AN ASENAPINE-CONTAINING PATCH
#228Inhalers and related methods
#229Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#230TOPICAL PHARMACEUTICAL FORMULATIONS OF A CYCLIC DEPSIPEPTIDE
#231Skin Protectant Paste
#232Nano-emulsion composition for tooth whitening and method for producing the same
#233COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF
#234Method of treating urolithiasis
#235Methods of manufacturing microspheres
#236TREATMENT OF CUTANEOUS ADVERSE EFFECTS CAUSED BY ONCOLOGICAL THERAPY WITH TOPICAL TAPINAROF COMPOSITIONS
#237PHARMACEUTICAL COMPOSITION
#238TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUE
#239COMPOSITIONS AND METHODS FOR DELIVERING CANNABINOIDS TO SKIN
#240OPHTHALMIC COMPOSITIONS COMPRISING CICLOSPORIN
#241READY-TO-USE BUPIVISONE PLUS LIQUID FORMULATION
#242SUSPENSION COMPRISING A PROTEIN PARTICLE SUSPENDED IN A NON-AQUEOUS VEHICLE
#243MANUFACTURING OF SELENIUM DISULFIDE COMPOSITIONS
#244composition
#245DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF
#246DEVICE, METHODS AND USES FOR TREATING ANAPHYLAXIS
#247COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION
#248DISSOLVED C60 AND METHOD OF PRODUCING DISSOLVED C60
#249METERED DOSE FOR DEMODEX AND DISORDERS RELATED THERETO
#250TERPENE-ENRICHED CANNABINOID COMPOSITION
#251THERMOGELLING CANNABINOID COMPOSITION AND METHOD OF MANUFACTURE AND USE THEREOF
#252ULTRASOUND PHANTOM
#253ANTI-CD47/ANTI-PD-L1 MULTIPLE ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF
#254ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES
#255Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
#256SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES
#257PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS
#258TOPICAL FORMULATION
#259TOPICAL COMPOSITION COMPRISING TACROLIMUS
#260Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture
#261METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF
#262TREATMENT OF IMMUNE EVASIVE TUMORS
#263Long Chain Fatty Acid Compound Colloidal Sulfur Formulations Comprising Functional Ingredients For Acne Treatment And Other Application
#2641-alkoxyethyl-4-isobutyl-benzene as aroma ingredients
#265TRANSDERMAL PERMEATION ENHANCING COMPOSITION AND APPLICATION THEREOF IN TIMOLOL PREPARATION
#266TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS
#267LIQUID TOPICAL PREPARATION
#268COMPOSITIONS COMPRISING PLANT EXTRACTS AND OILS AND RELATED METHODS OF TREATMENT AND THEIR PREPARATION
#269Methods and compositions particularly for treatment of attention deficit disorder
#270Topical compositions and methods for treating skin diseases
#271OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY
#272THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#273METHOD AND COMPOSITION FOR TREATMENT OF SKIN DISEASES ASSOCIATED WITH ACCELERATED CORNEODESMOSOMES DEGRADATION OR WEAKER CELL-CELL ADHESION
#274TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES
#275COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#276Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies
#277TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS
#278Topical formulation for a JAK inhibitor
#279TOPICAL FORMULATION FOR A JAK INHIBITOR
#280TRANSDERMAL FORMULATIONS
#281Pharmaceutical compositions of testosterone
#282NON-IRRITATING TESTOSTERONE EMULSIONS
#283CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION
#284Topical roflumilast formulation having antifungal properties
#285Compositions Comprising Milk Fat Globules
#286Paraffin wax with CBD isolate
#287COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
#288Iodine compositions
#289Methods to grow then harvest and process insects
#290COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEOVASCULARIZATION
#291Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
#292EXTERNAL AGENT FOR SKIN OR MUCOUS MEMBRANE AND PRODUCTION METHOD THEREOF, AND BASE FOR EXTERNAL AGENT FOR SKIN OR MUCOUS MEMBRANE
#293ROTIGOTINE STABILIZATION METHOD
#294Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
#295DELIVERY OF AEROSOLIZED MICROMOLAR COMPOSITION CONCENTRATIONS
#296TREATMENT OF ALOPECIA AREATA
#297OIL/SURFACTANT MIXTURES FOR SELF-EMULSIFICATION
#298Lipid barrier repair
#299COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES
#300N-substituted tetrahydrothienopyridine derivatives and uses thereof